Access to Information Requests Completed - January 2015

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of January 2015
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2010-00164 Correspondence from this institution to any third party in respect of "Guidance for Sponsors: Information and Submission Requirements for Subsequence Entry Biologics (SEBs)" (Mar 1, 2010 to May 7, 2010) Disclosed in part 79
A-2012-00476 Communication documents relating to prescription drug shortages excluding transactional and draft documents. (Nov 1, 2011 to May 31, 2012) Disclosed in part 176
A-2012-00626 Any reports commissioned by Health Canada reviewing the health effects of Truehope's EMPowerplus pills Disclosed in part 175
A-2012-00689 Documents pertaining to guidelines to prevent marketing unhealthy foods and/or sugar sweetened foods to children in Canada. (Jul 1, 2011 to Aug 8, 2012) Disclosed in part 52
A-2012-01105 Documents pertaining to a loss listed in the 2011 Public Accounts of Canada for $8,399,000 for false or fraudulent claims for contributions (3 cases). Disclosed in part 883
A-2012-01110 Documents pertaining to a loss listed in the 2011 Public Accounts of Canada document for $5,511,249 for overpayments - Non-Insured Health Services Providers (5 cases) Disclosed in part 60
A-2012-01375 Adverse Reaction Report (AER) for Rocuronium. (Jan 1, 2009 to Jan 21, 2013). Disclosed in part 94
A-2014-00026 Correspondence including media/communication staff regarding Safety Code 6 (Jan 1, 2014 to Mar 21, 2014) Disclosed in part 682
A-2014-00411 Information regarding MedCannAccess (8437726 Canada Inc.) in regard to the applications and/or reports held by Health Canada over the past 5 years. Disclosed in part 326
A-2014-00424 Documents pertaining to application or prospective application under the Marihuana for Medical Purposes Regulations concerning prospective licensing of a marihuana production site at 1668 Foster's Way in Delta, British Columbia. (Mar 1, 2013 to Jul 29, 2014) Disclosed in part 140
A-2014-00528 Departmental guidelines, practices, frameworks and/or rubrics in relation to the Treasury Board Secretariat's Reduce Redundant, Outdated and Trivial Content web visibility plan. All disclosed 242
A-2014-00585 Information regarding ARTICHOKE COMPOUND TABLETS, Drug Identification Number (DIN) 02063980 by Pharmetics (2011) Inc. Disclosed in part 35
A-2014-00589 Adverse Reaction Report (AER) for HUMIRA. Report numbers: E2B_00043467, EB2_00044050, E2B_00043902. All disclosed 47
A-2014-00593 Adverse Reaction Report (AER) for HUMIRA. Report numbers: 000562020, 000573670, E2B_00044149. Disclosed in part 27
A-2014-00681 All documents in Ministerial Executive Correspondence System for various subject matters for the following files: 13-119833-499, 14-102053-308, 14-101614-628, 14-102069-431, 14-100494-220, 14-102087-984, 14-102680-299, 14-101684-516, 14-101759-445, 14-101500-906, 14-103062-747, 14-001280-284, 14-103474-534, 14-102904-471, 14-001280-284, 14-102069-431, 14-103783-737, 14-104384-332, 13-119245-551, 14-104519-421, 14-103657-702, 14-104891-669, 14-102321-986 and 13-118942-23 Disclosed in part 95
A-2014-00762 Information held by the institute regarding the Marihuana for Medical Purposes Regulations (MMPR) pertaining to growing medical marihuana in greenhouses. Disclosed in part 58
A-2014-00807 All documents in Ministerial Executive Correspondence System for various subject matters for the following files: 13-109504-659, 13-109095-460, 13-109833-361 and 13-109707-486 Disclosed in part 28
A-2014-00819 Documents pertaining to the statement issued by Health Canada on the Canadian Cancer Society's recent report. (Oct 1, 2014 to Oct 16, 2014) Disclosed in part 18
A-2014-00831 Adverse Reaction Report (AER). Report numbers: 000506530 and 000517348. Disclosed in part 8
A-2014-00839 Adverse Reaction Reports (AER) for the following products/report numbers: Cipralex (000598381,000604471, 000605074, 000605466, 000611856, 000612675 & E2B_00079185), Celexa (000605958, 000606181, 000609133 & 000612981), Treanda (000602081 & 000602476) Disclosed in part 67
A-2014-00848 Information regarding the medical devices #10-1227, #10-1247, #10-1248, #10-1250, #10-1300 and #10-1305, License number 62 by Benlan Inc.. Disclosed in part 42
A-2014-00858 Copy of all files concerning Prescott S.M. Inc. and Prescott Apex Sanitation Inc. Disclosed in part 15
A-2014-00881 Documents prepared by or for the minister, the minister's office or the deputy minister's office regarding human health impacts of oilsands development. (Jul 1, 2014 to Sep 15, 2014) Disclosed in part 64
A-2014-00885 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00062605. Disclosed in part 32
A-2014-00886 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00058443. Disclosed in part 11
A-2014-00887 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00054442. Disclosed in part 27
A-2014-00889 Adverse Reaction Report (AER) for Eligard (leuprolide acetate). Report number: E2B_00026282. All disclosed 16
A-2014-00892 Adverse Reaction Report (AER) for Gliclazide. Report numbers: 000597450, 000588908, 000594419, 000581647 Disclosed in part 9
A-2014-00909 Adverse Reaction Report (AER) for Plaquenil (Hydroxychloroquine sulfate). Report number: E2B_00071544. Disclosed in part 30
A-2014-00917 Adverse Reaction Report (AER) for Plaquenil (hydroxychloroquine sulfate). Report numbers: E2B_00044694, 000578769, E2B_00044149, 000578131. Disclosed in part 37
A-2014-00919 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00059832. Disclosed in part 19
A-2014-00921 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00054746. Disclosed in part 12
A-2014-00925 Adverse Reaction Report (AER) for Demerol (meperidine hydrochloride). Report numbers: 000581947 and 000581507. Disclosed in part 4
A-2014-00928 Adverse Reaction Report (AER) for Plaquenil (hydroxychloroquine sulfate). Report number: 000533155. Disclosed in part 5
A-2014-00929 Adverse Reaction Report (AER) for Arava (leflunomide). Report number: 2B_00000856. Disclosed in part 16
A-2014-00930 Adverse Reaction Report (AER) for Arava (leflunomide). Report number: E2B_00062636. Disclosed in part 12
A-2014-00931 Adverse Reaction Report (AER) for Arava (leflunomide). Report number: 000522866. Disclosed in part 34
A-2014-00936 Adverse Reaction Report (AER) for Zaroxolyn (metolazone). Report number: E2B_00043427. All disclosed 17
A-2014-00937 Adverse Reaction Report (AER) for Arava (leflunomide). Report number: 000547621. Disclosed in part 187
A-2014-00949 Adverse Reaction Report (AER) for NORVIR. Report numbers: 000604480, 000606215 and E2B_00102274. Disclosed in part 38
A-2014-00960 List of briefing materials prepared for the Deputy Minister (Sep 1, 2014 to Nov 10, 2014) Disclosed in part 9
A-2014-00967 Adverse Reaction Report (AER) for Arava (leflunomide). Report numbers: E2B_00044003, and 000536074. Disclosed in part 13
A-2014-00971 Documents pertaining to event at the National Microbiology Laboratory on November 3, 2014, involving the Health Minister and the Chief Public Officer. All disclosed 9
A-2014-00996 Documentation pertaining to the guidelines used by the institution to evaluate applications to become a licensed producer under the Marihuana for Medical Purposes Program in relation with approval process, security clearances, preliminary inspection, proposed sited and risk to public health and safety. Disclosed in part 33
A-2014-01107 All call-ups/Contracts processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of Sep 1, 2014 to Nov 30, 2014. All disclosed 2
A-2014-01109 All call-ups/Contracts processed by this institution in the Western Region, specifically the city of Calgary, the Pacific Region, specifically the cities of Vancouver, Burnaby, Langley, Abbotsford and Surry, The Greater Toronto Area and the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of Aug 1, 2014 and Sep 30, 2014. All disclosed 6
A-2014-01120 Adverse Reaction Report (AER) for Lantus (insulin glargine). Report number: 000600163. Disclosed in part 2
A-2014-01122 Information regarding Health Canada employees in the Ottawa-Gatineau Region who took sick leave on the following dates: Dec. 23, 2013, Dec. 27, 2013, Apr. 17, 2014, Apr. 22, 2014, June 30, 2014, Nov. 10, 2014, Nov. 28, 2014. Also provide the average for sick leave taken, by day, Monday to Friday, per month, during 2013. All disclosed 2
A-2014-01127 Documents pertaining to the evaluation of Retailers' Behaviour Towards Certain Youth Access-to-Tobacco Restriction, MERX Solicitation #1000156554. No records exist 0
A-2014-01131 Documentation which indicates all appointments term and casual employees by Health Canada in the National Capital Region under the term of the Public Service Employment Act (May 1, 2014 to Sep 30, 2014.) All disclosed 2
A-2014-01144 Correspondence to Rona Ambrose and Dr. Gregory Taylor regarding the measures established to manage the influx of e-mails. No records exist 0
A-2014-01145 Documentation which indicates all appointments term and casual employees by Public Health Agency of Canada in the National Capital Region under the term of the Public Service Employment Act (May 1, 2014 to Sep 30, 2014) All disclosed 2
A-2014-01149 Adverse Reaction Report (AER) for WinRho SDF. Report number: 000592930. Disclosed in part 3
A-2014-01152 Documents pertaining to the evaluation of the pesticide program, MERX Solicitation # 1000159290. No records exist 0
A-2014-01161 Information regarding the AutoTrends Heated Seat Cover, number 1X032-3508. (Jan 1, 2009 to Dec 31, 2014) No records exist 0
A-2014-01162 Procedural document used for the investigations in the First Nations and Inuit Health Branch (FNIHB), Quebec Region, with regard to both management and human resources. All disclosed 8
A-2014-01163 Documents pertaining to Brucellosis cases reported in Canada including cases reported in Ontario for the past 15-20 years identifying whether the disease is from endemic transmission or imported. No records exist 0
A-2014-01165 Information regarding applications to be Licensed Producers under the Marihuana for Medical Purposes Regulations (MMPR) (Jun 1, 2013 to Dec 23, 2014) All disclosed 1
A-2014-01167 Copy of the Memorandum of Understanding (MOU) between Health Canada and Capital Medical University in Beijing, China. No records exist 0
A-2014-01168 Documentation prepared for the Minister for the visit of a Chinese delegation from International Cooperation of the State Administrator of Traditional Chinese Medecine (SATCM) (December 2014) No records exist 0
A-2014-01180 The list of all external contracts awarded by Health Canada to computer consultants for each of the following years: 2010, 2011, 2012, 2013 and 2014, up to Dec. 27, 2014. All disclosed 6
A-2014-01181 The list of all external contracts awarded by Health Canada to computer equipment suppliers for the following years: 2010, 2011, 2012, 2013 and 2014, up to Dec. 27, 2014. All disclosed 41
A-2014-01188 Documents pertaining to benzene, toluene, ethylbenzene, xylenes or to BTEX (an acronym which refers to a mixture of those substances) and/or petroleum derivatives with respect to the following parties, equipment and location: industrial facility owned and operated by ADM Agri-Industries Company and/or ADM Agri-Industries Ltd (Windsor, ON) (May 11, 2008 to Jan 5, 2015) No records exist 0
A-2014-01189 Documents pertaining to inspections, violations, citations, certifications or other records related to benzene, toluene, ethylvenzene, zylenes or BTEX (an acronym which refers to a mixture of those substances) and/or petroleum derivatives with respect to the following parties, equipment, and locations: tractors, trailers, trucks, other transport vehicles and related hoses and/or vehicle and transport accessories owned by and/or operated by Gorski Bulk Transport Inc. (May 1, 2008 to Jan 1, 2015) No records exist 0
A-2014-01205 Documents concerning the reasons for excluding menthol from the list of prohibited additives as part of the amendments to the Tobacco Act proposed in October 2014. No records exist 0
Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: